Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels

Sex differences in 5-year risk of major adverse cardiovascular events in patients with coronary artery disease and elevated lipoprotein(a) levels

Aim. To evaluate 5-year major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) and high lipoprotein(a) (Lp(a)) levels in the Uzbek population.Material and methods. The study included 216 patients (96 men and 120 women) hospitalized with a diagnosis of "CAD. Pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. B. Alieva, A. B. Shek, A. A. Abdullaev, H. G. Fozilov, Sh. U. Khoshimov, G. D. Abdullaeva, D. Zakirova, L. E. Kan, A. R. Kim, R. A. Kurbanova, D. B. Yusupalieva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2025-04-01
Series:	Российский кардиологический журнал
Subjects:	high lipoprotein(a) level quantitative real-time pcr coronary artery disease major cardiovascular events sex differences
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/6019
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypothyroidism consequent to thyroidectomy is associated with elevated remnant lipoproteins and cholesterol enrichment of triglyceride-rich lipoproteins: an observational study
by: Adrian Post, et al.
Published: (2025-04-01)

The Association of Lipoprotein(a) with Major Adverse Cardiovascular Events after Acute Myocardial Infarction: A Meta-Analysis of Cohort Studies
by: Huiruo Liu, et al.
Published: (2025-05-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Value of Epicardial Adipose Tissue Thickness in Predicting Major Adverse Cardiovascular Events in Patients with Coronary Artery Disease and Metabolic Syndrome
by: Andrey R. Kim, et al.
Published: (2025-03-01)

Effects of the combined use of atorvastatin and curcetin on inflammatory biomarkers in patients with unstable angina after COVID-19 (“Long COVID”)
by: R. B. Alieva, et al.
Published: (2023-03-01)

Reduced Capacity of High‐Density Lipoprotein to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men
by: Sophie Galier, et al.
Published: (2024-08-01)

Elevated high-density lipoprotein triglycerides increase atherosclerotic risk
by: Weifang Liu, et al.
Published: (2025-05-01)

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore
by: Wann Jia Loh, et al.
Published: (2025-02-01)

Lipoprotein(a) throughout life in women
by: Pablo Corral, et al.
Published: (2024-12-01)

BLOOD LIPOPROTEINS AS A PLATFORM FOR TRANSPORT OF HYDROPHILIC AND HYDROPHOBIC COMPOUNDS
by: L. M. Polyakov, et al.
Published: (2019-09-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Neutrophil to high-density lipoprotein cholesterol ratio predicts left ventricular remodeling and MACE after PCI in patients with acute ST-segment elevation myocardial infarction
by: Jianlin Chen, et al.
Published: (2025-04-01)

The correlation between lipoprotein(a) and major adverse cardiovascular events in patients with acute myocardial infarction combined with heart failure with preserved ejection fraction
by: Xiaodong Zhang, et al.
Published: (2025-06-01)

High density lipoproteins of blood plasma as a transport form of actinomycin D
by: L. M. Polyakov, et al.
Published: (2019-01-01)

Elevated Lipoprotein(a) Predicts Stent Edge Restenosis and Adverse Two-Year Outcomes After PCI: An Intravascular Ultrasound Study
by: Wu X, et al.
Published: (2025-07-01)

DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA
by: P. V. Pigarevsky, et al.
Published: (2014-07-01)

Antibodies to low-density lipoproteins modified by malonic dialdehyde: contents in blood and role in atherogenesis
by: A. A. Ivanova, et al.
Published: (2025-01-01)

Prognostic value of lipoprotein(a) for cardiovascular events after lower limb revascularization in diabetic patients with chronic limb-threatening ischemia
by: Federico Biscetti, et al.
Published: (2025-07-01)

High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01)

Hindlll polymorphism of lipoprotein lipase gene in patients with acute coronary syndrome
by: R. T. Saygitov, et al.
Published: (2008-12-01)

Triglyceride to high density lipoprotein cholesterol ratio and major adverse cardiovascular events in ACS patients undergoing PCI
by: Shangxun Zhou, et al.
Published: (2024-12-01)

Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease
by: Robert S. Rosenson, et al.
Published: (2025-06-01)

Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies
by: Wong Nathan D.
Published: (2025-01-01)

An Efficacy of Seligi Leaf Flour Fermentation on Cholesterol Levels, Low Density Lipoprotein, and High Density Lipoprotein in Catfish
by: Reza Hardiansyah, et al.
Published: (2022-04-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study)
by: P. S. Sadovnikov, et al.
Published: (2024-10-01)

Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
by: Mei Dong, et al.
Published: (2025-01-01)

Association of low-density lipoprotein/high-density lipoprotein ratio with cognition, Alzheimer’s disease biomarkers and brain structure
by: Zihao Zhang, et al.
Published: (2025-04-01)

Utilizing the Electronic Health Record to Evaluate Lipoprotein(a) Testing Within a Large Regional Health System
by: Kamil F. Faridi, MD, MSc, et al.
Published: (2025-01-01)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

The Impact of Diet on Lipoprotein(a) Levels
by: Michał Stojko, et al.
Published: (2024-10-01)

Lipoprotein(a) and Cardiovascular Disease in People Living With HIV: The Next Horizon
by: David B. Hanna, et al.
Published: (2024-12-01)

Prepartum and postpartum concentrations of lipids and lipoproteins in dairy cows
by: Mutlu Sevinç, et al.

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

Lipoprotein(a) and panvascular disease
by: Ruiyan Xu, et al.
Published: (2025-05-01)

Elevated neutrophil to high-density lipoprotein ratio predicts pneumonia in patients with intracerebral hemorrhage
by: Yuning Feng, et al.
Published: (2025-07-01)